Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Moodys
Harvard Business School
AstraZeneca
Colorcon
McKesson
Johnson and Johnson

Last Updated: January 28, 2022

DrugPatentWatch Database Preview

Investigational Drug Information for Meso-Erythritol


Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug Meso-Erythritol?

Meso-Erythritol is an investigational drug.

There have been 21 clinical trials for Meso-Erythritol. The most recent clinical trial was a Phase 2 trial, which was initiated on June 1st 2018.

The most common disease conditions in clinical trials are Mesothelioma, Malignant, Mesothelioma, and Carcinoma, Ovarian Epithelial. The leading clinical trial sponsors are Hrain Biotechnology Co., Ltd., Hrain Biotechnology Co.,Ltd., and Stony Brook University.

There are fifteen US patents protecting this investigational drug and five hundred and twenty-six international patents.

Recent Clinical Trials for Meso-Erythritol
TitleSponsorPhase
Efficacy of Sunlight Activated Synthetic Porphyrin in COVID-19 Infected PatientsKafrelsheikh UniversityPhase 1
Evaluation of the Implementation and Effectiveness of Intermittent Preventive Treatment for Malaria Using Dihydroartemisinin-piperaquine on Reducing Malaria Burden in School Aged Children in TanzaniaNational Malaria Control Program, TanzaniaPhase 4
Evaluation of the Implementation and Effectiveness of Intermittent Preventive Treatment for Malaria Using Dihydroartemisinin-piperaquine on Reducing Malaria Burden in School Aged Children in TanzaniaNational Institute for Medical Research, TanzaniaPhase 4

See all Meso-Erythritol clinical trials

Clinical Trial Summary for Meso-Erythritol

Top disease conditions for Meso-Erythritol
Top clinical trial sponsors for Meso-Erythritol

See all Meso-Erythritol clinical trials

US Patents for Meso-Erythritol

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Meso-Erythritol ⤷  Sign up for a Free Trial Composition for relieving subjective symptoms of fatigue Kyowa Hakko Bio Co., Ltd. (Tokyo, JP) ⤷  Sign up for a Free Trial
Meso-Erythritol ⤷  Sign up for a Free Trial Methods for the electrolytic production of erythrose or erythritol Dynamic Food Ingredients Corporation (Kirkland, WA) ⤷  Sign up for a Free Trial
Meso-Erythritol ⤷  Sign up for a Free Trial High-potency sweetener composition with rubisco protein, rubiscolin, rubiscolin derivatives, ace inhibitory peptides, and combinations thereof, and compositions sweetened therewith The Coca-Cola Company (Atlanta, GA) ⤷  Sign up for a Free Trial
Meso-Erythritol ⤷  Sign up for a Free Trial High-potency sweetener composition with vitamin and compositions sweetened therewith The Coca-Cola Company (Atlanta, GA) ⤷  Sign up for a Free Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Meso-Erythritol

Drugname Country Document Number Estimated Expiration Related US Patent
Meso-Erythritol Australia AU8494291 2010-08-31 ⤷  Sign up for a Free Trial
Meso-Erythritol Canada CA2090620 2010-08-31 ⤷  Sign up for a Free Trial
Meso-Erythritol European Patent Office EP0548138 2010-08-31 ⤷  Sign up for a Free Trial
Meso-Erythritol Japan JPH06504364 2010-08-31 ⤷  Sign up for a Free Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Harvard Business School
AstraZeneca
Colorcon
McKesson
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.